Evidence-Based Complementary and Alternative Medicine

Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018


Publishing date
01 Sep 2018
Status
Published
Submission deadline
20 Apr 2018

Lead Editor

1Al-Qasemi Academic College, Baqa Al-Gharbiyye, Israel

2Central Drug Research Institute, Lucknow, India

3The Forsyth Institute, Cambridge, USA

4Johannes Gutenberg University, Mainz, Germany


Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018

Description

In the modern and contemporary world, the incidence of metabolic disorders and diabetes (especially type 2) is rising continuously due to modernization in life style and unhealthy dietary habits. Herbal medicines can be beneficial against such ailments. Indeed, nature is the best cooker of medicines due to the fact that natural products have been optimized to interact optimally with the biological systems through a long natural selection process. Natural products therefore has been a source of therapeutics for millennia, and during the past century, many drugs were developed from natural sources. Currently, we are witnessing a great progress in evidence-based modern medicine and pharmacology. The characterization of pharmacological and biological effects of herbal-based medicines is becoming more competitive and complex, with the involvement in this research area of experts belonging to different scientific fields, including botany, chemistry, biochemistry, immunology, molecular biology and bioinformatics. However, despite this great progress in evidence-based modern medicine and pharmacology, traditional medicinal plants continues to be practiced without regulations in many countries. It is crucial hence to keep on studying medicinal plants efficacy in vitro and in vivo including their toxicity in order to prevent their abuse.

We invite investigators to contribute original research and review articles dealing with the physiological as well as molecular and biochemical efficacy of medicinal plants and natural active compounds in treating metabolic disorders and diabetes in vitro and in vivo. We are interested in articles that explore aspects of medicinal plants and their active compounds in metabolic disorders, insulin sensitizing and particularly in the research of new molecular targets directly related to metabolic disorders and type 2 diabetes.

Potential topics include but are not limited to the following:

Potential topics include but are not limited to the following:

  • Isolation and characterization of novel medicinal plants active compounds possessing anti-diabetic and metabolic disorders potential benefits.
  • Recent advances in drug discovery from medicinal plants with anti-diabetic and anti- metabolic disorders potentials.
  • Identification and validation of novel targets of medicinal plants and active compounds insulin sensitizer, as well as studies of related fuel metabolism.
  • Identification of the cellular target of the effective anti-diabetic plant extract(s), e.g. proteins and genes involved in the insulin action pathway.
  • Therapeutic benefits of currently used plant-extracted supplements and their underlying biological, and molecular mechanisms in delaying evolvement of metabolic diseases
  • Potential association between systemic diseases and metabolic diseases, and benefits of reducing systemic diseases with plant extracts on progression of metabolic diseases

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 5843298
  • - Editorial

Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018

Hilal Zaid | Akhilesh K. Tamrakar | ... | Thomas Efferth
  • Special Issue
  • - Volume 2018
  • - Article ID 4341961
  • - Research Article

Clinical Investigations of the Effect of Citrus unshiu Peel Pellet on Obesity and Lipid Profile

Seongil Kang | Sangyeol Song | ... | Sanghun Lee
  • Special Issue
  • - Volume 2018
  • - Article ID 3248521
  • - Research Article

Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic Rats

Xin Qiu | Xinyu Wei | ... | Fuer Lu
  • Special Issue
  • - Volume 2018
  • - Article ID 7926452
  • - Research Article

“Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018”: Antihyperglycemic Activity of Hamelia patens Jacq. Extracts

Catalina Rugerio-Escalona | Cynthia Ordaz-Pichardo | ... | Fabiola E. Jiménez-Montejo
  • Special Issue
  • - Volume 2018
  • - Article ID 5269731
  • - Research Article

Synergistic Effect of Bupleuri Radix and Scutellariae Radix on Adipogenesis and AMP-Activated Protein Kinase: A Network Pharmacological Approach

Jueun Lee | Jinbong Park | ... | Jae-Young Um
  • Special Issue
  • - Volume 2018
  • - Article ID 7154702
  • - Research Article

In Vitro Antidiabetic Effects of Isolated Triterpene Glycoside Fraction from Gymnema sylvestre

Rashmi S. Shenoy | K. V. Harish Prashanth | H. K. Manonmani
  • Special Issue
  • - Volume 2018
  • - Article ID 3565427
  • - Research Article

The Effect of Morinda citrifolia L. Fruit Juice on the Blood Sugar Level and Other Serum Parameters in Patients with Diabetes Type 2

Petra Algenstaedt | Alexandra Stumpenhagen | Johannes Westendorf
  • Special Issue
  • - Volume 2018
  • - Article ID 5490491
  • - Research Article

Metabolomics-Based Clinical Efficacy and Effect on the Endogenous Metabolites of Tangzhiqing Tablet, a Chinese Patent Medicine for Type 2 Diabetes Mellitus with Hypertriglyceridemia

Jia Liu | Ziqiang Li | ... | Yuhong Huang
  • Special Issue
  • - Volume 2018
  • - Article ID 8781352
  • - Research Article

Identification of Digestive Enzyme Inhibitors from Ludwigia octovalvis (Jacq.) P.H.Raven

Dulce Morales | Guillermo Ramirez | ... | Alejandro Zamilpa
  • Special Issue
  • - Volume 2018
  • - Article ID 2409471
  • - Research Article

Zuo Gui Wan Alters Expression of Energy Metabolism Genes and Prevents Cell Death in High-Glucose Loaded Mouse Embryos

Qi Liang | Zhipeng Qu | ... | David L. Adelson
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.